Wikisage, the free encyclopedia of the second generation, is digital heritage

Difference between revisions of "Drisapersen"

From Wikisage
Jump to navigation Jump to search
m
Line 1: Line 1:
 
An exon skipping experimental [[drug|Medicine]]<ref>https://web.archive.org/web/20120729012249/http://www.prosensa.eu/technology-and-products/pipeline/pro051gsk2402968</ref>
 
An exon skipping experimental [[drug|Medicine]]<ref>https://web.archive.org/web/20120729012249/http://www.prosensa.eu/technology-and-products/pipeline/pro051gsk2402968</ref>
 
<ref>https://www.whocc.no/atc_ddd_index/?code=M09AX04</ref>
 
<ref>https://www.whocc.no/atc_ddd_index/?code=M09AX04</ref>
PRO051/GSK2402968 is considered an orphan drug
+
PRO051/GSK2402968 is considered an orphan drug.
Drisapersen
+
'''Drisapersen'''
 
differs from eteplirsen in that it is an 18-mer 2′O-methyl phosphorothioate type of AO, which is negatively charged <ref>[https://www.dovepress.com/eteplirsen-in-the-treatment-of-duchenne-muscular-dystrophy-peer-reviewed-fulltext-article-DDDT Eteplirsen in the treatment of Duchenne muscular dystrophy]</ref>
 
differs from eteplirsen in that it is an 18-mer 2′O-methyl phosphorothioate type of AO, which is negatively charged <ref>[https://www.dovepress.com/eteplirsen-in-the-treatment-of-duchenne-muscular-dystrophy-peer-reviewed-fulltext-article-DDDT Eteplirsen in the treatment of Duchenne muscular dystrophy]</ref>
 
[[Duchenne muscular distrophy]]
 
[[Duchenne muscular distrophy]]

Revision as of 23:41, 11 September 2019